Anzeige
Mehr »
Login
Freitag, 03.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Schnelle Produktionsaufnahme: Multi-Tenbagger-Potenzial direkt in Spanien?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
305 Leser
Artikel bewerten:
(1)

Mayo Clinic Launches Imaging Solution to Enable Digital Pathology Across the Enterprise

LINKÖPING, Sweden and SHELTON, Connecticut, June 25, 2020 /PRNewswire/ -- In support of Mayo Clinic's digital health and practice transformation initiatives, the Mayo Clinic Department of Laboratory Medicine and Pathology has initiated an enterprise-wide digital pathology implementation of the Sectra digital slide review and image storage and management system to enable digital pathology.

"As Mayo Clinic continues to lead the transformation of health care delivery and accessibility, the laboratories and pathology practice play an essential role," says William Morice, II, M.D., Ph.D., president of Mayo Clinic Laboratories and chair of the department. "This system implementation will elevate our pathology practice by enabling digital collaboration among pathologists throughout the Mayo Clinic system and, ultimately, Mayo Clinic Laboratories clients around the world. In the near future, our pathologists will be able to virtually collaborate with colleagues anywhere to provide answers to the most complex pathology cases in order to help our partners deliver the best patient care."

In collaboration with Sectra, a digital slide review and image storage and management system has been implemented for the Mayo Clinic practice in Rochester for the first phase of the roll out. Once proof of concept, system testing, and configuration activities are complete, the digital pathology solution will be introduced gradually to Mayo Clinic departments throughout Rochester, Florida, and Arizona, as well as the Mayo Clinic Health System. The new digital intake process will be piloted with a domestic Mayo Clinic Laboratories client later this year.

"We are confident the Sectra digital pathology solution will positively impact patient care by improving access and availability of our patients' pathology material in a digital form, and facilitating enterprise-wide collaboration and integration of innovative technologies," says Taofic Mounajjed, M.D., Mayo Clinic pathologist and one of the leaders of the digital pathology initiative. "Our pathologists and allied staff are looking forward to the opportunities that digital pathology will bring in transforming our practice by improving operational efficiency."

Last year, the Mayo Clinic Division of Anatomic Pathology performed nearly 200,000 pathology consultations in support of the Mayo Clinic practice and more than 1,100 health care organizations around the world. Specializing in rare and complex pathology cases across all medical subspecialties, the new solution will enable the pathology practice to enact additional operational efficiencies, leverage image sharing and collaboration features, and build a digital pathology image archive to advance educational, research, and artificial intelligence and machine learning initiatives.

"We look forward to working with Mayo Clinic as we understand the critical need of delivering a solution that will allow pathologists to easily review cases, collaborate, and make primary diagnoses, regardless of their geographic location, all in the best interests of patient care," says Mikael Anden, president of Sectra, Inc.

Media contacts:
Suzanne Ferguson, Mayo Clinic, 507-284-5005, newsbureau@mayo.edu
Andrea Sowitch, Sectra, 203-925-0899 ext. 268, andrea.sowitch@sectra.com

About the Department of Laboratory Medicine and Pathology and Mayo Clinic Laboratories

The Mayo Clinic Department of Laboratory Medicine and Pathology and its reference laboratory, Mayo Clinic Laboratories, provide advanced testing and pathology services to support 4,000 health care organizations around the world. Revenue from this testing supports medical education and research at Mayo Clinic, a nonprofit worldwide leader in medical care, research, and education. Complemented by collaborations with diagnostic and biotechnology companies, the department maintains a robust diagnostic test development program, launching more than 150 new tests each year.

About Sectra
With more than 30 years of innovation and approaching 2,000 installations worldwide, Sectra is a leading global provider of imaging IT solutions that support health care in achieving patient-centric care. Sectra offers an enterprise imaging solution comprising PACS for imaging-intense departments (radiology, pathology, cardiology, orthopedics), VNA, and share and collaborate solutions. Sectra received FDA approval for its digital pathology module in March 2020 and is leading the way in digital pathology with multiple fully digital installations throughout the world. Read more about Sectra and why Sectra PACS is "Best in KLAS" at https://medical.sectra.com/.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/sectra/r/mayo-clinic-launches-imaging-solution-to-enable-digital-pathology-across-the-enterprise,c3142199

The following files are available for download:

https://news.cision.com/sectra/i/sectra-s-digital-pathology-solution,c2800467

Sectra's digital pathology solution

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2020 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.